| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Cardiff Oncology, Inc. | Former Director | Stock Options | 76.1K | $198K | $2.60 | Jun 10, 2021 | Direct |
| OKYO Pharma Ltd | Chief Executive Officer, Director | American Depositary Shares | 12.5K | $50K | $4.00 | May 19, 2022 | Direct |
| Hepion Pharmaceuticals, Inc. | Director | Stock Options | 102K | Feb 19, 2024 | Direct | ||
| Virpax Pharmaceuticals, Inc. | Director | Stock Option (right to buy) | 12.1K | Jan 1, 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| HEPA | Hepion Pharmaceuticals, Inc. | Feb 19, 2024 | 1 | $0 | 4 | Feb 21, 2024 | Director |
| OKYO | OKYO Pharma Ltd | May 19, 2022 | 1 | $50K | 4 | May 19, 2022 | Chief Executive Officer, Director |
| OKYO | OKYO Pharma Ltd | May 16, 2022 | 0 | $0 | 3 | May 16, 2022 | Chief Executive Officer, Director |
| VRPX | Virpax Pharmaceuticals, Inc. | Jan 1, 2022 | 1 | $0 | 4 | Jan 5, 2022 | Director |
| CRDF | Cardiff Oncology, Inc. | Jun 10, 2021 | 8 | $0 | 4 | Jun 15, 2021 | Former Director |
| HEPA | Hepion Pharmaceuticals, Inc. | May 18, 2021 | 1 | $0 | 4 | May 20, 2021 | Director |